Increasing Drug Importation To Lower Prices for American Patients

What it means

Directs the Secretary of Health and Human Services to expand access to lower-cost imported prescription drugs, including insulin. The order allows individuals to import medications that cost less abroad, facilitates re-importation of insulin for emergency care, and implements rules for Canadian drug imports.

Expected impact

• Potential reduction in prescription drug prices for American patients, possibly up to 20% for certain medications
• Increased access to affordable medications, particularly insulin, for those with chronic conditions
• Greater market competition that could pressure domestic pharmaceutical companies to reconsider pricing strategies
• Possible resistance from pharmaceutical industry stakeholders concerned about revenue impacts
• Implementation challenges related to safety verification and supply chain logistics